A.P.U.D. type endocrine tumour of the prostate. Incidence and prognosis in association with adenocarcinoma
Dauge, M.C.; Delmas, V.
Progress in Clinical and Biological Research 243a: 529-531
1987
ISSN/ISBN: 0361-7742 PMID: 2889216 Document Number: 292019
Document emailed within 1 workday
Related Documents
Modigliani, E. 1998: Type 2 endocrine neoplasms. Prognosis and therapeutic problems Presse Medicale 27(13): 638-640Zu, F.; Bi, Y.; Yao, X.; Wang, H.; Zhou, L.; Li, N. 2014: An association study of six-transmembrane protein of prostate 2 gene with metabolic index and tumour necrosis factor in Uygur population Zhonghua Nei Ke Za Zhi 53(2): 131-134
Corsi, A.; Bosman, C. 1995: Adenocarcinoma and atypical carcinoid: morphological study of a gastric collision-type tumour in the carcinoma-carcinoid spectrum Italian Journal of Gastroenterology 27(6): 303-308
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Vaidya, H.C.; Wolf, B.A.; Garrett, N.; Catalona, W.J.; Clayman, R.V.; Nahm, M.H. 1988: Extremely high values of prostate-specific antigen in patients with adenocarcinoma of the prostate; demonstration of the "hook effect" Clinical Chemistry 34(10): 2175-2177
Giovannini, M.; Payan, M.J.; Choux, R.; Sarles, H. 1987: Association, in the same patient, of benign hepatic duct adenoma, thyroid adenocarcinoma and colonic adenocarcinoma Presse Medicale 16(28): 1372
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Shimazaki, J.; Fuse, H.; Ohshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K.; Saito, Y. 1991: Clinical studies on endocrine therapy for prostatic carcinoma (4): Initial response to endocrine therapy and prognosis Hinyokika Kiyo. Acta Urologica Japonica 37(11): 1505-1510
Hessman, O.; Lindberg, D.; Skogseid, B.; Carling, T.; Hellman, P.; Rastad, J.; Akerström, G.; Westin, G. 1998: Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas Cancer Research 58(3): 377-379
Lehy, T.; Cadiot, G.; Mignon, M.; Ruszniewski, P.; Bonfils, S. 1992: Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome Gut 33(9): 1275-1279
Rahardjo, D.; Kamil, S.T.; Pakasi, L.S. 2000: Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 563-570
Obara, T.; Yamashita, T.; Kanbe, M.; Ito, Y.; Egawa, S.; Yamaguchi, K. 1995: Multiple endocrine neoplasia type 2A, type 2B and familial medullary thyroid carcinoma syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 53(11): 2708-2715
De Toma, G.; Plocco, M.; Nicolanti, V.; Brozzetti, S.; Letizia, C.; Cavallaro, A. 2001: Type B1 thymoma in multiple endocrine neoplasia type 1 (MEN-1) syndrome Tumori 87(4): 266-268
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Srebro, Z.; Pierscinska, E.; Szirmai, E. 1974: A morphometric study of some endocrine organs in ascites tumour-bearing mice Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 15(4): 247-253
Finan, B.; Atkinson, W.E.; Cockrill, H.H.; Landgren, R.C.; Ross, S.W. 1987: Adenocarcinoma of the prostate Journal of the Arkansas Medical Society 84(7): 283-284
Touré, L.; Bédard, J.; Sawan, B.; Mosimann, Fçois. 2010: Case note: intrapancreatic accessory spleen mimicking a pancreatic endocrine tumour Canadian Journal of Surgery. Journal Canadien de Chirurgie 53(1): E1-E2
Vesalainen, S.; Lipponen, P.; Nordling, S.; Talja, M.; Syrjänen, K. 1995: Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology Anticancer Research 15(2): 569-573
De Siati, M.; Busolo, A.; Contin, F.; Shah, J.; Visonà, A.; Franzolin, N. 1999: High grade phyllodes tumour of the prostate Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 71(4): 225-227
Rathore, A.; Chatterjee, A.; Sivarama, P.; Yamamoto, N.; Singhal, P.K.; Dhole, T.N. 2009: Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians Aids Research and Human Retroviruses 25(11): 1149-1156